药物与临床
ZHOU Yi;HUANG He;ZHAO Yiping;YE Song
2005, 24(12): 0-0.
ObjectiveTo survey and assess the therapeutic effectiveness and safety rate of keganzhi capsules (KGZC) in the treatment of fatty liver.Methods48 qualified patients with fatty liver were randomly divided into 2 equal groups, the trial group and control group.Patients of the trial group and control group were given each 5 KGZCs and 3 tablets of Dongbaogantai (DBGT) PO, t.i.d., respectively.The course of treatment in both groups lasted 3 months.A 3month followup study was carried out after the termination of the treatment.Before and after the treatment as well as during the followup study, each patient of the 2 groups was submitted to determination of the body weight, waisthip ratio, blood lipids (TC, TG), liver function (ALT, AST GGT) as well as Bmode ultrasonic examination.Routine examinations of the stool, urine and blood, renal function tests and ECG examination were carried out for all of the patients before and after the treatment.ResultsStriking improvement in body weight, waisthip ratio, liver function, blood lipids and the state of the fatty liver as revealed by Bmode ultrasonography was demonstrated in patients of both groups after the treatment and during the followup study as compared with the corresponding results before the treatment (P<0.05).The differences between patients of the two groups with respect to reduction of body weight and waisthip ratio, improvement in liver function and decrement of serum total cholesterol (TC) were insignificant (P>0.05).However, the amelioration of subjective symptoms, the extent of the decline of serum triglycerides (TG) and improvement in the state of fatty liver as revealed by Bmode ultrasonography in patients of the trial group were by far superior to those in patients of the control group (P<0.05).During the followup study 3 months after the termination of the treatment, the extent of the decline of serum TG in patients of the trial group was still significantly greater than that in patients of the control group (P<0.05).ConclusionKGZC was shown to reduce the body weight and waisthip ratio, lower blood lipid level and improve liver function in patients with fatty liver .No major adverse reactions were encountered.It is therefore a safe and effective traditional Chinese medicine for the treatment of fatty liver.